Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies

Secondary antibody deficiencies (SAD) may require immunoglobulin replacement therapy (IgRT). While the intravenous route (IVIG) is broadly considered effective in SAD, the use of subcutaneous immunoglobulins (SCIG) is mainly adopted from the experience in primary antibody deficiencies (PAD), where S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Cinetto, Francesco, Neri, Raffaella, Vianello, Fabrizio, Visentin, Andrea, Barilà, Gregorio, Gianese, Sabrina, Lanciarotta, Alison, Milito, Cinzia, Rattazzi, Marcello, Piazza, Francesco, Trentin, Livio, Zambello, Renato, Agostini, Carlo, Scarpa, Riccardo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7932095/
https://ncbi.nlm.nih.gov/pubmed/33661940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247717
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge